Leading Element Driving Change in the Self-Administered Parenteral Market in 2025: Chronic Diseases Fueling Self-Administered Parenteral Market Expansion Driver

"What combination of drivers is leading to accelerated growth in the self-administered parenteral market?
The increasing prevalence of chronic illnesses is anticipated to drive the expansion of the self-administered parenteral market. Chronic diseases are enduring health conditions that typically develop gradually and frequently necessitate continuous care and treatment. Self-administered parenteral products play a pivotal role in managing chronic conditions, allowing individuals to control their treatments, which can result in increased adherence over oral medications. To illustrate, the National Institutes of Health, a US government agency, projected that by January 2023, there would be a 99.5% increase in individuals aged 50 and above suffering from at least one chronic disease, from 71.522 million in 2020 to 142.66 million by 2050. Consequently, this rise in chronic disease prevalence is propelling the growth of the self-administered parenteral market.

Get Your Self-Administered Parenteral Market Report Here:
https://www.thebusinessresearchcompany.com/report/self-administered-parenteral-global-market-report

What is the projected compound annual growth rate (CAGR) of the self-administered parenteral market from 2025 to 2034, and what factors influence it?
In recent times, the self-administered parenteral market has seen robust growth. Projected to increase from $24.57 billion in 2024 to $26.04 billion in 2025, it has a compound annual growth rate (CAGR) of 6.0%. This growth in the previous period was primarily driven by the increase in chronic diseases, an aging global population, government policy changes, patient educational initiatives, support programs, and a spike in bone disorder cases.

The market size of self-administered parenteral treatments is predicted to experience consistent expansion in the coming years, reaching a value of $31.18 billion in 2029 with a 4.6% compound annual growth rate (CAGR). The expected growth during the forecast period is due to factors such as a rising preference for home healthcare among patients, advancements in telemedicine and remote patient monitoring, enhanced patient education and support measures, along with the increase in personalized medicine. Key trends expected to shape the market during the forecast period include the incorporation of digital health solutions, tailored drug delivery systems, the development of targeted therapies, and advancements in biologics.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13927&type=smp

How are the latest trends influencing the growth of the self-administered parenteral market?
Leading firms in the self-administered parenteral industry are concentrating on the creation of groundbreaking products such as the UDENYCA autoinjector, with the aim to extend options and control to patients, thereby enhancing the accessibility of treatments. An autoinjector is a medical apparatus specifically engineered to administer a single dosage of a specific drug, with its design geared towards easy usage, and the drug administration set off reliably and instantly by skin contact. For example, Coherus BioSciences Inc., a biotech firm based in the US, unveiled the UDENYCA autoinjector in May 2023. This self-administered parenteral medication available in the US is a solitary-dose, pre-filled autoinjector that provides patients with an alternative route for administering pegfilgrastim. Its design is user-friendly and intuitive, with skin contact triggering drug delivery, guaranteeing a full pegfilgrastim dose is dispensed instantly and reliably. Moreover, it provides several features that facilitate successful delivery such as quick dosage, intuitive design, dual coverage and options for both home and office use, in addition to reducing the risk of febrile neutropenia.

What are the major segments of the self-administered parenteral market and their role in driving growth?
The self-administered parenteral market covered in this report is segmented -

1) By Product: Pre-Filled Syringes, Autoinjectors, Pen Injectors, Other Products
2) By Usage: Disposable, Reusable
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Home Healthcare Providers, Specialty Clinics, Other Distribution Channels
4) By Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, Other Applications

Subsegments:
1) By Pre-Filled Syringes: Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes
2) By Autoinjectors: Disposable Autoinjectors, Reusable Autoinjectors
3) By Pen Injectors: Insulin Pen Injectors, Growth Hormone Pen Injectors, Other Pen Injectors
4) By Other Products: Infusion Pumps, Needle-Free Injectors, Combination Devices

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13927

North America was the largest region in the self-administered parenteral market in 2024. The regions covered in the self-administered parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the self-administered parenteral market?
Major companies operating in the self-administered parenteral market report are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC, Roche Holding AG, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Terumo Corporation, Catalent Inc., Dexcom Inc., West Pharmaceutical Services Inc., Gerresheimer AG, Biocon Limited, Insulet Corporation, Halozyme Therapeutics Inc., Ypsomed AG, Antares Pharma Inc., SHL Medical AG, Owen Mumford Ltd., Novartis AG, Kaleo Inc., Haselmeier AG, Bespak (A Consort Medical Company), Senseonics Holdings Inc., ScPharmaceuticals Inc., Fresenius Kabi AG

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13927&type=smp

What Is Covered In The Self-Administered Parenteral Global Market Report?

•Market Size Forecast: Examine the self-administered parenteral market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the self-administered parenteral market for a structured understanding.
•Key Players Overview: Analyze major players in the self-administered parenteral market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the self-administered parenteral market.
•Segment Contributions: Evaluate how different segments drive overall growth in the self-administered parenteral market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the self-administered parenteral market.
•Industry Challenges: Identify potential risks and obstacles affecting the self-administered parenteral market.
•Competitive Landscape: Review strategic developments in the self-administered parenteral market, including expansions, agreements, and new product launches.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
•LinkedIn: https://in.linkedin.com/company/the-business-research-company
•Twitter: https://twitter.com/tbrc_info
•YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.